Candida peritonitis
- PMID: 17327742
- DOI: 10.1097/MCC.0b013e328028fd92
Candida peritonitis
Abstract
Purpose of review: The review highlights current insights in the epidemiology, diagnosis and therapy of Candida peritonitis, focusing on complicated secondary and tertiary peritonitis.
Recent findings: Candida peritonitis is still associated with poor prognosis. Antifungal prophylaxis is therefore recommended in patients with an overt risk profile for invasive candidiasis (immunodeficiency and prior antibiotic exposure). The clinical and microbiological diagnosis of Candida peritonitis remains problematic. It is still unclear which peritonitis patients may benefit from antifungal treatment. Antifungal therapy can be suggested in critically ill patients with nosocomial peritonitis where Candida is diagnosed based on perioperatively sampled peritoneal fluid. Patients with prior exposure to fluconazole are at risk for Candida nonalbicans spp. involvement with possible reduced susceptibility.
Summary: The main challenge in Candida peritonitis remains the interpretation of Candida cultured from the peritoneal cavity. Future research should focus on more conclusive diagnosis and on factors potentially confounding outcome, such as site of the perforation and failure of surgical source control. While awaiting progress to discriminate Candida colonization from invasive infection, antifungal therapy is recommended in high-risk critically ill surgical patients. Rapid detection of Candida might be beneficial in this regard. Besides antifungal therapy, adequate source control is of key importance.
Similar articles
-
Is Candida really a threat in the ICU?Curr Opin Crit Care. 2008 Oct;14(5):600-4. doi: 10.1097/MCC.0b013e32830f1dff. Curr Opin Crit Care. 2008. PMID: 18787456 Review.
-
Non Candida albicans fungal peritonitis in continuous ambulatory peritoneal dialysis patients.Adv Perit Dial. 2001;17:176-9. Adv Perit Dial. 2001. PMID: 11510270
-
[Candida peritonitis].Enferm Infecc Microbiol Clin. 2010 Sep;28 Suppl 2:42-8. doi: 10.1016/S0213-005X(10)70029-X. Enferm Infecc Microbiol Clin. 2010. PMID: 21130929 Review. Spanish.
-
Candida prophylaxis and therapy in the ICU.Semin Respir Crit Care Med. 2011 Apr;32(2):159-73. doi: 10.1055/s-0031-1275528. Epub 2011 Apr 19. Semin Respir Crit Care Med. 2011. PMID: 21506052 Review.
-
Invasive Candida species infection: the importance of adequate empirical antifungal therapy.J Antimicrob Chemother. 2007 Sep;60(3):459-60. doi: 10.1093/jac/dkm260. Epub 2007 Jul 23. J Antimicrob Chemother. 2007. PMID: 17646200
Cited by
-
A focus on intra-abdominal infections.World J Emerg Surg. 2010 Mar 19;5:9. doi: 10.1186/1749-7922-5-9. World J Emerg Surg. 2010. PMID: 20302628 Free PMC article.
-
Discriminating invasive fungal infection from colonization.Crit Care. 2008;12(2):412; author reply 412. doi: 10.1186/cc6835. Crit Care. 2008. PMID: 18439323 Free PMC article. No abstract available.
-
Invasive Candida Infection after Upper Gastrointestinal Tract Surgery for Gastric Cancer.Int J Surg Oncol. 2017;2017:6058567. doi: 10.1155/2017/6058567. Epub 2017 Nov 6. Int J Surg Oncol. 2017. PMID: 29234525 Free PMC article.
-
Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment.PLoS One. 2016 Apr 28;11(4):e0153247. doi: 10.1371/journal.pone.0153247. eCollection 2016. PLoS One. 2016. PMID: 27123857 Free PMC article.
-
Essentials for selecting antimicrobial therapy for intra-abdominal infections.Drugs. 2012 Apr 16;72(6):e17-32. doi: 10.2165/11599800-000000000-00000. Drugs. 2012. PMID: 22480338 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous